Author Archives: Steve Walker

McConnell willing to hold Senate vote on bipartisan health deal if Trump endorses, but what are the odds of passage?

The News: Senator Mitch McConnell of Kentucky, the majority leader, said on Sunday (October 22, 2017) that he would be willing to bring a bipartisan proposal to stabilize health insurance… Read more »

Report says US hospitals still marking up drug prices by 500%. This must stop, and China’s got the right answer.

The News: Hospitals markup medicine prices, on average, nearly 500%, according to a new analysis from the Moran Company that was commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). The… Read more »

Study suggests patients less likely to die if surgeon is female; more patient-centered care and superior communication the likely reason.

The News: Women have long struggled for equal recognition in the male-dominated medical profession, but a new study suggests that female surgeons may have the upper–and possibly steadier–hand. Patients who… Read more »

Kaiser report says America hitting the wall as new gene-therapies rise above $1 million; “personalized” medicine looks great, but we won’t all get access to it.

The News: Posted by Kaiser Health News–on October 17, 2017 Out­rage over the high cost of can­cer care has fo­cused on sky­rock­et­ing drug prices, in­clud­ing the $475,000 price tag for the coun­try’s… Read more »

MannKind’s 10-year quest for insulin product Afrezza gets last-ditch chance; time to buy, or run?

The News: Last week, MannKind Corp. (Nasdaq:MNKD) led advancing stocks in the healthcare sector, soaring 151% to $5.03, after saying it won a labeling concession from the FDA on its Afrezza inhalable… Read more »

Trump does end-run around Congress, scraps Obamacare insurer subsidies via executive order; what’s really happening?

The News: An alliance of US states joined ranks on Friday (October 13, 2017) to sue to block President Donald Trump’s move to dump a key component of Obamacare–subsidies to… Read more »

China’s FDA to accept foreign trial data for accelerated approvals; sounds great, but future enforcement of IP rights poses threat to US Pharma.

The News: For decades, patients in China have fought to gain access to cutting-edge medicines thanks to bureaucratic delays that have thwarted drug development. Now a sweeping government overhaul of… Read more »

Innovio’s DNA-based Zika vaccine is safe and effective at inducing immune response; where has this breakthrough vaccine technique been hiding?

The News: A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc. (Plymouth Meeting PA) and South Korea’s GeneOne Life Science Inc. induced anti-Zika immune responses in an early stage human trial,… Read more »